Cyclacel Pharmaceuticals マネジメント
マネジメント 基準チェック /34
現在、CEO に関する十分な情報がありません。
主要情報
Spiro Rombotis
最高経営責任者
US$661.0k
報酬総額
| CEO給与比率 | 84.7% |
| CEO在任期間 | 27.3yrs |
| CEOの所有権 | 1.5% |
| 経営陣の平均在職期間 | データなし |
| 取締役会の平均在任期間 | 8.2yrs |
経営陣の近況
Recent updates
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Will Have To Spend Its Cash Wisely
Aug 17
Cyclacel: Trading At Less Than Half Its Cash Value, Near-Term Catalysts, No Obvious Bear Thesis
Aug 07Is Cyclacel Pharmaceuticals (NASDAQ:CYCC) In A Good Position To Invest In Growth?
Apr 15Cyclacel CEO Spiro Rombotis - Addressing Cancer Resistance (Video)
Oct 04Cyclacel issues key business objectives for 2021
Jan 11Cyclacel Pharma inks securities purchase agreement for $7M
Dec 22Cyclacel Pharmaceuticals EPS misses by $1.74
Nov 11CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$13m |
| Jun 30 2024 | n/a | n/a | -US$18m |
| Mar 31 2024 | n/a | n/a | -US$20m |
| Dec 31 2023 | US$661k | US$560k | -US$23m |
| Sep 30 2023 | n/a | n/a | -US$25m |
| Jun 30 2023 | n/a | n/a | -US$24m |
| Mar 31 2023 | n/a | n/a | -US$23m |
| Dec 31 2022 | US$764k | US$546k | -US$21m |
| Sep 30 2022 | n/a | n/a | -US$19m |
| Jun 30 2022 | n/a | n/a | -US$19m |
| Mar 31 2022 | n/a | n/a | -US$20m |
| Dec 31 2021 | US$1m | US$531k | -US$19m |
| Sep 30 2021 | n/a | n/a | -US$20m |
| Jun 30 2021 | n/a | n/a | -US$18m |
| Mar 31 2021 | n/a | n/a | -US$15m |
| Dec 31 2020 | US$1m | US$531k | -US$12m |
| Sep 30 2020 | n/a | n/a | -US$8m |
| Jun 30 2020 | n/a | n/a | -US$8m |
| Mar 31 2020 | n/a | n/a | -US$7m |
| Dec 31 2019 | US$1m | US$531k | -US$8m |
| Sep 30 2019 | n/a | n/a | -US$8m |
| Jun 30 2019 | n/a | n/a | -US$8m |
| Mar 31 2019 | n/a | n/a | -US$8m |
| Dec 31 2018 | US$753k | US$531k | -US$7m |
| Sep 30 2018 | n/a | n/a | -US$8m |
| Jun 30 2018 | n/a | n/a | -US$14m |
| Mar 31 2018 | n/a | n/a | -US$15m |
| Dec 31 2017 | US$776k | US$531k | -US$15m |
報酬と市場: Spiroの 総報酬 ($USD 661.05K ) は、 US市場 ($USD 652.28K ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Spiroの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Spiro Rombotis (65 yo)
27.3yrs
在職期間
US$661,049
報酬
Mr. Spiro George Rombotis has been President of Cyclacel Pharmaceuticals Inc. (formerly, Cyclacel Pharmaceuticals, Inc. (formerly known as Cyclacel Group plc)) since August 1997 and has been its Founding C...
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 18.7yrs | US$661.05k | 1.52% $ 10.4k | |
| Executive VP of Finance | 18.7yrs | US$352.62k | 0.82% $ 5.6k | |
| Chief Medical Officer & Director | 3.9yrs | US$84.49k | 0.85% $ 5.8k | |
| Independent Chair of the Board | 10.2yrs | US$97.99k | 0.21% $ 1.4k | |
| Independent Director | 18.7yrs | US$136.99k | 0.21% $ 1.4k | |
| Independent Director | 4yrs | US$95.49k | 0.21% $ 1.5k | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Independent Vice Chairman | 6.2yrs | US$115.99k | 0.21% $ 1.4k | |
| Independent Director | 2.4yrs | US$85.49k | 0.20% $ 1.3k |
8.2yrs
平均在職期間
68yo
平均年齢
経験豊富なボード: CYCCの 取締役会 は 経験豊富 であると考えられます ( 8.2年の平均在任期間)。